Drug Approval | October 31, 2025
The FW500 is designed to meet the evolving needs of mid-sized diagnostic laboratories
INEOS production of BDO in Germany, which produces a vital ingredient for antibiotics, statins and vitamin B6, is being crushed by a flood of carbon heavy imports and product dumping from the Far East
The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta
Expanding US operations to address the increased demand for API development and manufacturing
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
The new plant will manufacture high-quality Type I borosilicate glass tubing
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
The new line features advanced isolator technology to deliver enhanced sterility assurance, throughput and operational precision
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
Subscribe To Our Newsletter & Stay Updated
